Title: Hyperinsulinemic Hypoglycemia: Masquerading as a Case of Seizure Disorder
Authors: Gupta Akanksha, Singhal Deepika, Rustagi Vaishakhi, Chopra Saurabh
DOI: https://dx.doi.org/10.18535/jmscr/v6i2.167
Abstract
Hypoglycemia is one of the most important acquired causes of neurodevelopmental delay in neonates as well as infants and children. We present a case of 20 months old toddler with congenital hyperinsulinemic hypoglycemia presenting with abnormal oromotor movements who was being treated as a case of seizure disorder,was managed with Glucose infusion and diazoxide. Only high index of suspicion and early and aggressive management of hypoglycemia is the key to good neurological outcome.
Keywords: Hyperinsulinemic hypoglycemia, developmental delay, hypoglycemia.
References
- Daly LP,Osterhoudt KC,Weinzimer SA. Presenting features of idiopathic ketotic hypoglycemia. J Emerg Med.2003;25 (1):39-43.
- Cryer P. Diverse Causes of Hypoglycemia-Associated Autonomic Failure in Diabetes. N Engl J Med. 2004;350(22):2272-2279.
- Bonnefont J, Specola N, Vassault A, Lombes A, Ogier H, de Klerk J et al. The fasting test in paediatrics: Application to the diagnosis of pathological hypo- and hyperketotic states. Eur J Pediatrics.1990;150(2):80-85.
- Bellannι-Chantelot C , Saint-Martin C, Ribeiro MJ et al. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide- unresponsive congenital hyperinsulinism. J Med Genet. 2010;47 (11):752-759.
- Flanagan SE, Kapoor RR, Hussain K. Genetics of congenital hyperinsulinemic hypoglycemia. Semin Pediatr Surg. 2011;20(1):13-17.
- Senniappan S, Arya VB, Hussain K. The molecular mechanisms, diagnosis and management of congenital hyperinsulinism. Indian J Endocr Metab. 2013;17:19-30.
- Kim-Hanh Le QS, Jean-Baptiste A, Asmaa M, Saint-Martin C, Bellannι-Chantelot C, Valayannopoulos, et al. Successful treatment of congenital hyperinsulinism with long-acting release octreotide. Eur J Endocrino. 2012;166:333-9.
- Kuhnen P, Marquard J, Ernert A, Meissner T, Raile K, Wannenmacher G, et al. Long-term lanreotide treatment in six patients with congenital hyperinsulinism. Horm Res Paediatr.2012;78(2):106–12.
- Senniappan S, Alexandrescu S, Tatevian N, Shah P, Arya V, Flanagan S, et al. Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia. N Engl J Med. 2014;370:1131-7.